Debasmita Dutta

1.1k total citations
29 papers, 478 citations indexed

About

Debasmita Dutta is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Debasmita Dutta has authored 29 papers receiving a total of 478 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 8 papers in Oncology and 6 papers in Cancer Research. Recurrent topics in Debasmita Dutta's work include Natural product bioactivities and synthesis (7 papers), Cancer, Hypoxia, and Metabolism (4 papers) and RNA Interference and Gene Delivery (3 papers). Debasmita Dutta is often cited by papers focused on Natural product bioactivities and synthesis (7 papers), Cancer, Hypoxia, and Metabolism (4 papers) and RNA Interference and Gene Delivery (3 papers). Debasmita Dutta collaborates with scholars based in United States, India and Saudi Arabia. Debasmita Dutta's co-authors include Biswajit Mukherjee, Chinmay Chowdhury, Padma Das, Biswajit Chakraborty, Mohiuddin Quadir, Nakul C. Maiti, Sreya Gupta, Laboni Mondal, Mita Chatterjee Debnath and Soumyabrata Banerjee and has published in prestigious journals such as Blood, PLoS ONE and Cancer Research.

In The Last Decade

Debasmita Dutta

26 papers receiving 471 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Debasmita Dutta United States 13 246 98 67 61 50 29 478
Vladimíra Svobodová Pavlíčková Czechia 12 201 0.8× 57 0.6× 85 1.3× 61 1.0× 41 0.8× 23 420
Zhongcheng Ke China 10 213 0.9× 117 1.2× 42 0.6× 55 0.9× 34 0.7× 26 486
Eun Hyang Jang South Korea 14 179 0.7× 112 1.1× 83 1.2× 51 0.8× 32 0.6× 17 388
Mahesh Kumar Teli India 13 257 1.0× 46 0.5× 54 0.8× 43 0.7× 71 1.4× 24 527
Jamal Mohammadian Iran 12 186 0.8× 95 1.0× 53 0.8× 56 0.9× 31 0.6× 21 383
Farnoosh Attari Iran 12 234 1.0× 65 0.7× 80 1.2× 25 0.4× 34 0.7× 20 452
Ying Zheng China 10 247 1.0× 55 0.6× 113 1.7× 44 0.7× 39 0.8× 37 470
Xin Cai China 13 178 0.7× 46 0.5× 41 0.6× 62 1.0× 40 0.8× 39 545
Xingang Liu China 12 249 1.0× 79 0.8× 72 1.1× 65 1.1× 38 0.8× 31 474
Anindita De India 11 241 1.0× 100 1.0× 75 1.1× 53 0.9× 21 0.4× 22 447

Countries citing papers authored by Debasmita Dutta

Since Specialization
Citations

This map shows the geographic impact of Debasmita Dutta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Debasmita Dutta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Debasmita Dutta more than expected).

Fields of papers citing papers by Debasmita Dutta

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Debasmita Dutta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Debasmita Dutta. The network helps show where Debasmita Dutta may publish in the future.

Co-authorship network of co-authors of Debasmita Dutta

This figure shows the co-authorship network connecting the top 25 collaborators of Debasmita Dutta. A scholar is included among the top collaborators of Debasmita Dutta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Debasmita Dutta. Debasmita Dutta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dutta, Debasmita, Chowdhury S. Abdullah, Richa Aishwarya, et al.. (2025). Mechanistic Underpinnings of Epigenetic Enzyme-Responsive Nanoparticles. ACS Applied Bio Materials. 8(5). 3845–3857. 2 indexed citations
2.
3.
Dutta, Debasmita, Priyanka Ray, Archana De, et al.. (2024). pH-responsive targeted nanoparticles release ERK-inhibitor in the hypoxic zone and sensitize free gemcitabine in mutant K-Ras-addicted pancreatic cancer cells and mouse model. PLoS ONE. 19(4). e0297749–e0297749. 4 indexed citations
4.
Dutta, Debasmita, Jun Hyoung Park, Chinmay Chowdhury, et al.. (2024). EpCAM-targeted betulinic acid analogue nanotherapy improves therapeutic efficacy and induces anti-tumorigenic immune response in colorectal cancer tumor microenvironment. Journal of Biomedical Science. 31(1). 81–81. 9 indexed citations
5.
Murthy, Divya, Debasmita Dutta, Kuldeep S. Attri, et al.. (2024). CD24 negativity reprograms mitochondrial metabolism to PPARα and NF-κB-driven fatty acid β-oxidation in triple-negative breast cancer. Cancer Letters. 587. 216724–216724. 15 indexed citations
6.
Dutta, Debasmita, Jiye Liu, Kenneth Wen, et al.. (2024). Lipid Nanoparticle-Mediated Combinational mRNA Vaccine for Multiple Myeloma: The Next Stage of Cancer Immunotherapy. Blood. 144(Supplement 1). 3278–3278. 1 indexed citations
7.
8.
Dutta, Debasmita, Leena Kumari, Biswajit Mukherjee, et al.. (2023). ΔPSap4#5 surface-functionalized abiraterone-loaded nanoparticle successfully inhibits carcinogen-induced prostate cancer in mice: a mechanistic investigation. Cancer Nanotechnology. 14(1). 8 indexed citations
9.
Dutta, Debasmita, Jiye Liu, Kenneth Wen, et al.. (2023). BCMA-targeted bortezomib nanotherapy improves therapeutic efficacy, overcomes resistance, and modulates the immune microenvironment in multiple myeloma. Blood Cancer Journal. 13(1). 184–184. 12 indexed citations
10.
Gaonkar, Raghuvir H., et al.. (2022). Inhibitory potential of iRGD peptide-conjugated garcinol-loaded biodegradable nanoparticles in rat colorectal carcinoma. Biomaterials Advances. 134. 112714–112714. 14 indexed citations
11.
Dutta, Debasmita, Sanku Mallik, Sabha Ganai, et al.. (2021). Polymeric Composite Matrix with High Biobased Content as Pharmaceutically Relevant Molecular Encapsulation and Release Platform. ACS Applied Materials & Interfaces. 13(34). 40229–40248. 15 indexed citations
12.
Basu, S., Debasmita Dutta, Jayoti Das, & Surajit Kumar Hazra. (2021). Influence of Metal Contacts on Graphene Based Chemical Sensor Devices. 3(3). 1–9.
13.
Abdullah, Chowdhury S., Priyanka Ray, Shafiul Alam, et al.. (2020). Chemical Architecture of Block Copolymers Differentially Abrogate Cardiotoxicity and Maintain the Anticancer Efficacy of Doxorubicin. Molecular Pharmaceutics. 17(12). 4676–4690. 27 indexed citations
14.
Ray, Priyanka, Debasmita Dutta, Inamul Haque, et al.. (2020). pH-Sensitive Nanodrug Carriers for Codelivery of ERK Inhibitor and Gemcitabine Enhance the Inhibition of Tumor Growth in Pancreatic Cancer. Molecular Pharmaceutics. 18(1). 87–100. 37 indexed citations
15.
Kale, Narendra, et al.. (2020). Functional Applications of Polyarginine-Hyaluronic Acid-Based Electrostatic Complexes. PubMed. 2(2). 158–166. 5 indexed citations
16.
Mondal, Laboni, Biswajit Mukherjee, Kaushik Das, et al.. (2019). <p>CD-340 functionalized doxorubicin-loaded nanoparticle induces apoptosis and reduces tumor volume along with drug-related cardiotoxicity in mice</p>. International Journal of Nanomedicine. Volume 14. 8073–8094. 33 indexed citations
17.
Dutta, Debasmita, et al.. (2019). Nanoencapsulated betulinic acid analogue distinctively improves colorectal carcinoma in vitro and in vivo. Scientific Reports. 9(1). 11506–11506. 43 indexed citations
18.
Dutta, Debasmita, et al.. (2017). [Point mutations in the DNA binding domain of p53 contribute to glioma progression and poor prognosis].. PubMed. 51(2). 334–341. 6 indexed citations
19.
Dutta, Debasmita, Biswajit Chakraborty, Ankita Sarkar, Chinmay Chowdhury, & Padma Das. (2016). A potent betulinic acid analogue ascertains an antagonistic mechanism between autophagy and proteasomal degradation pathway in HT-29 cells. BMC Cancer. 16(1). 23–23. 33 indexed citations
20.
Chakraborty, Biswajit, et al.. (2015). Synthesis and biological evaluation of a novel betulinic acid derivative as an inducer of apoptosis in human colon carcinoma cells (HT-29). European Journal of Medicinal Chemistry. 102. 93–105. 75 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Vladimíra Svobodová Pavlíčková Breakdown of academic impact, for papers by Zhongcheng Ke Breakdown of academic impact, for papers by Eun Hyang Jang Breakdown of academic impact, for papers by Mahesh Kumar Teli Breakdown of academic impact, for papers by Jamal Mohammadian Breakdown of academic impact, for papers by Farnoosh Attari Breakdown of academic impact, for papers by Ying Zheng Breakdown of academic impact, for papers by Xin Cai Breakdown of academic impact, for papers by Xingang Liu Breakdown of academic impact, for papers by Anindita De
Rankless by CCL
2026